A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer

Anna M Sawka; Sangeet Ghai; George Tomlinson; Nancy N Baxter; Martin Corsten; Syed Ali Imran; Eric Bissada; Rebecca Lebouef; Nathalie Audet; Maryse Brassard; Han Zhang; Michael Gupta; Anthony C Nichols; Deric Morrison; Stephanie Johnson-Obeski; Eitan Prisman; Don Anderson; Shamir P Chandarana; Sana Ghaznavi; Jennifer Jones; Amiram Gafni; John J Matelski; Wei Xu; David P Goldstein; Canadian Thyroid Cancer Active Surveillance Study Group

doi:10.3389/fendo.2021.686996

A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer

Front Endocrinol (Lausanne). 2021 Jun 10:12:686996. doi: 10.3389/fendo.2021.686996. eCollection 2021.

Authors

Anna M Sawka¹, Sangeet Ghai², George Tomlinson³, Nancy N Baxter⁴, Martin Corsten⁵, Syed Ali Imran⁶, Eric Bissada⁷, Rebecca Lebouef⁸, Nathalie Audet⁹, Maryse Brassard¹⁰, Han Zhang¹¹, Michael Gupta¹², Anthony C Nichols¹², Deric Morrison¹³, Stephanie Johnson-Obeski¹⁴, Eitan Prisman¹⁵, Don Anderson¹⁵, Shamir P Chandarana¹⁶, Sana Ghaznavi¹⁷, Jennifer Jones¹⁸, Amiram Gafni¹⁹, John J Matelski²⁰, Wei Xu²¹, David P Goldstein²²; Canadian Thyroid Cancer Active Surveillance Study Group

Collaborators

Canadian Thyroid Cancer Active Surveillance Study Group:
Lorne Rotstein, Dale Brown, John de Almeida, Patrick Gullane, Ralph Gilbert, Douglas Chepeha, Jonathan Irish, Jesse Pasterna, Shereen Ezzat, James P Brierley, Richard W Tsang, Eric Monteiro, Afshan Zahedi, Jacqueline Jame, Karen Gomez Hernandez, Antoine Eskander, Danny Enepekides, Kevin Higgins, Ilana J Halperin, Afshan Zahedi, Karen Devon, Everton Gooden, Manish Shah, Mark Korman, Janet Chung, Kareem Nazarali, Eric Arruda, Artur Gevorgyan, Michael Chang, Sumeet Anand, Vinay Fernandes, Denny Lin, Avik Banerjee, Vinita Bindlish, Vinod Bharadwaj, Maky Hafidh, Raewyn Seaburg, Laura Whiteacre

Affiliations

¹ Division of Endocrinology, Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada.
² Joint Department of Medical Imaging, University Health Network-Mt Sinai Hospital-Women's College Hospital, University of Toronto, Toronto, ON, Canada.
³ Department of Medicine, University Health Network and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
⁴ Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
⁵ Department of Otolaryngology-Head and Neck Surgery, Dalhousie University, Halifax, NS, Canada.
⁶ Division of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
⁷ Department of Otolaryngology-Head and Neck Surgery, l'Université de Montréal, Montreal, QC, Canada.
⁸ Division of Endocrinology, Department of Medicine, l'Université de Montréal, Montreal, QC, Canada.
⁹ Department of Otolaryngology-Head and Neck Surgery, Université Laval, Quebec City, QC, Canada.
¹⁰ Division of Endocrinology, Department of Medicine, Université Laval, Quebec City, QC, Canada.
¹¹ Department of Otolaryngology-Head and Neck Surgery, McMaster University, Hamilton, ON, Canada.
¹² Department of Otolaryngology-Head and Neck Surgery, Western University, London, ON, Canada.
¹³ Division of Endocrinology, Department of Medicine, Western University, London, ON, Canada.
¹⁴ Department of Otolaryngology-Head & Neck Surgery, University of Ottawa, Ottawa, ON, Canada.
¹⁵ Department of Otolaryngology-Head & Neck Surgery, University of British Columbia, Vancouver, BC, Canada.
¹⁶ Section of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.
¹⁷ Division of Endocrinology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
¹⁸ Department of Psychosocial Oncology, University Health Network and University of Toronto, Toronto, ON, Canada.
¹⁹ Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, Canada.
²⁰ Mount Sinai Hospital, University of Toronto, Toronto, Biostatistics Research Unit, University Health Network, Toronto, ON, Canada.
²¹ Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
²² Department of Otolaryngology and Head and Neck Surgery, University Health Network and University of Toronto, Toronto, ON, Canada.

Abstract

Background: The traditional management of papillary thyroid cancer (PTC) is thyroidectomy (total or partial removal of the thyroid). Active surveillance (AS) may be considered as an alternative option for small, low risk PTC. AS involves close follow-up (including regularly scheduled clinical and radiological assessments), with the intention of intervening with surgery for disease progression or patient preference.

Methods: This is a protocol for a prospective, observational, long-term follow-up multi-centre Canadian cohort study. Consenting eligible adults with small, low risk PTC (< 2cm in maximal diameter, confined to the thyroid, and not immediately adjacent to critical structures in the neck) are offered the choice of AS or surgery for management of PTC. Patient participants are free to choose either option (AS or surgery) and the disease management course is thus not assigned by the investigators. Surgery is provided as usual care by a surgeon in an institution of the patient's choice. Our primary objective is to determine the rate of 'failure' of disease management in respective AS and surgical arms as defined by: i) AS arm - surgery for progression of PTC, and ii) surgical arm - surgery or other treatment for disease persistence or progression after completing initial treatment. Secondary outcomes include long-term thyroid oncologic and treatment outcomes, as well as patient-reported outcomes.

Discussion: The results from this study will provide long-term clinical and patient reported outcome evidence regarding active surveillance or immediate surgery for management of small, low risk PTC. This will inform future clinical trials in disease management of small, low risk papillary thyroid cancer.

Registration details: This prospective observational cohort study is registered on clinicaltrials.gov (NCT04624477), but it should not be considered a clinical trial as there is no assigned intervention and patients are free to choose either AS or surgery.

Keywords: active surveillance; observational cohort study; papillary thyroid cancer; papillary thyroid microcarcinoma; prospective research; thyroidectomy.

Copyright © 2021 Sawka, Ghai, Tomlinson, Baxter, Corsten, Imran, Bissada, Lebouef, Audet, Brassard, Zhang, Gupta, Nichols, Morrison, Johnson-Obeski, Prisman, Anderson, Chandarana, Ghaznavi, Jones, Gafni, Matelski, Xu, Goldstein and the Canadian Thyroid Cancer Active Surveillance Study Group.

Publication types

Clinical Trial Protocol
Research Support, Non-U.S. Gov't

MeSH terms

Disease Progression
Humans
Observational Studies as Topic
Patient Participation
Thyroid Cancer, Papillary / pathology
Thyroid Cancer, Papillary / surgery
Thyroid Cancer, Papillary / therapy*
Thyroid Gland / pathology
Thyroid Gland / surgery
Thyroid Neoplasms / pathology
Thyroid Neoplasms / surgery
Thyroid Neoplasms / therapy*
Thyroidectomy
Treatment Outcome
Watchful Waiting*

Associated data

ClinicalTrials.gov/NCT04624477

Abstract

Publication types

MeSH terms

Associated data

Grants and funding